Serious non-fatal adverse events and reporting rules: veterinary products - Q&A
This questions and answers document was developed to enable all stakeholders understand what constitutes a serious non-fatal adverse event following use of a veterinary medicinal product (VMP), after recommended or non-recommended use.
#RegulatoryAffairsVeterinary #LegislationPharmacovigilance #PharmacovigilanceRiskAssessmentCommittee
